Lee HW, Park YH, Kim KH, Jung EH, et al. Sequential intravesical mitomycin-C and gemcitabine therapy for BCG-unresponsive high-risk non-muscle-invasive bladder cancer: protocol for a prospective, open-label, single-arm, multicentre phase II (IMGeS) study. BMJ Open 2026;16:e117239.
PMID: 42957299